1 Cancer stem cells in Osteosarcoma
暂无分享,去创建一个
[1] H. Kwon,et al. Evaluating a therapeutic window for precision medicine by integrating genomic profiles and p53 network dynamics , 2018, Communications Biology.
[2] R. Khokha,et al. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 , 2017, Oncogene.
[3] F. Verrecchia,et al. TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression , 2016, Journal of clinical medicine.
[4] A. Abarrategi,et al. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies , 2016, Stem cells international.
[5] K. Pienta,et al. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer , 2016, Oncotarget.
[6] W. Park,et al. Deciphering intratumor heterogeneity using cancer genome analysis , 2016, Human Genetics.
[7] R. Clarke,et al. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling , 2016, Oncotarget.
[8] Anne-Marie Cleton-Jansen,et al. Osteosarcoma Stem Cells Have Active Wnt/β‐catenin and Overexpress SOX2 and KLF4 , 2016, Journal of cellular physiology.
[9] A. Cleton-Jansen,et al. Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling. , 2016, Cancer letters.
[10] Florian Engert,et al. Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency , 2015, Nature Communications.
[11] D. Placantonakis,et al. Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells , 2015, Nature Communications.
[12] P. Yuan,et al. Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression , 2014, Oncogene.
[13] B. Dawson,et al. Notch activation as a driver of osteogenic sarcoma. , 2014, Cancer cell.
[14] C. Swanton,et al. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine , 2014, Genome Biology.
[15] M. Si,et al. CD271+ Osteosarcoma Cells Display Stem-Like Properties , 2014, PloS one.
[16] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[17] R. Khokha,et al. High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures , 2014, Cancer medicine.
[18] N. Kosaka,et al. Clinical Relevance and Therapeutic Significance of MicroRNA‐133a Expression Profiles and Functions in Malignant Osteosarcoma‐Initiating Cells , 2014, Stem cells.
[19] J. Huard,et al. ALDH Activity Correlates with Metastatic Potential in Primary Sarcomas of Bone. , 2014, Journal of cancer therapy.
[20] R. Clarke,et al. Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity , 2013, Oncotarget.
[21] C. Basilico,et al. Perspectives on cancer stem cells in osteosarcoma. , 2013, Cancer letters.
[22] Hua Wang,et al. Transforming Growth Factor β1 Signal is Crucial for Dedifferentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma , 2013, Stem cells.
[23] Wei Liu,et al. CD133 expression in osteosarcoma and derivation of CD133⁺ cells. , 2013, Molecular medicine reports.
[24] F. Papaccio,et al. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] H. Johnsen,et al. Cancer stem cell definitions and terminology: the devil is in the details , 2012, Nature Reviews Cancer.
[26] Yang Yao,et al. CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study , 2012, Experimental and therapeutic medicine.
[27] A. Paiva,et al. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line , 2012, BMC Cancer.
[28] Zhuojing Luo,et al. Side population cells isolated from human osteosarcoma are enriched with tumor‐initiating cells , 2011, Cancer science.
[29] S. Orkin,et al. Sox2 maintains self-renewal of tumor initiating cells in osteosarcomas , 2011, Oncogene.
[30] Jingnan Shen,et al. Enrichment of osteosarcoma stem cells by chemotherapy , 2011, Chinese journal of cancer.
[31] F. Papaccio,et al. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[33] Chia-Ying Lin,et al. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99‐1 cells based on high aldehyde dehydrogenase activity , 2011, International journal of cancer.
[34] Toshio Mori,et al. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. , 2010, Oncology reports.
[35] N. Agarwal,et al. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. , 2010, Cancer research.
[36] Steven E. Brooks,et al. Lung metastasis 21 years after initial diagnosis of osteosarcoma: a case report , 2009, Journal of medical case reports.
[37] T. Yamashita,et al. Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas , 2009, British Journal of Cancer.
[38] Y. Takakura,et al. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. , 2009, International journal of oncology.
[39] H. Okano,et al. Tumor initiating potential of side population cells in human gastric cancer. , 2009, International journal of oncology.
[40] C. Cavaliere,et al. Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours , 2008, PloS one.
[41] A. Corradin,et al. The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. , 2008, Cancer research.
[42] M. Shibuya,et al. Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling , 2008, Oncogene.
[43] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[44] Edward W Scott,et al. Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.
[45] M. de Rosa,et al. Methods for cancer stem cell detection and isolation. , 2012, Methods in molecular biology.